312
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Assessment of Hematological Profiles and Prognostic Role of Hemogram-Derived Novel Markers for Diabetes Mellitus and Its Complications Among Type 2 Diabetes Mellitus Adult Patients Attending Bishoftu General Hospital, Central, Ethiopia: A Comparative Cross-Sectional Study

ORCID Icon, ORCID Icon, &
Pages 681-699 | Received 15 Aug 2023, Accepted 21 Dec 2023, Published online: 27 Dec 2023

References

  • World Health Organization. Geneva;Classification of Diabetes Mellitus. World Health Organization. 4–28. 2019.
  • American association Diabetes. Classification and diagnosis of diabetes: standards of medical care in diabetes. J Diabetes Care. 2019;42(1):13–28. doi:10.2337/dc19-S002
  • World Health Organization (WHO). Geneva:Diabetes Key Facts Overview. World Health Organization. 1–5. 2021.
  • International Diabetes Federation(IDF). IDF Diabetes Atlas. 10th ed. International Diabetes Federation(IDF); 2021: 9–65.
  • Zeru M, Tesfa E, Mitiku A, et al. Prevalence and risk factors of type-2 diabetes mellitus in Ethiopia: systematic review and meta-analysis. Sci Rep. 2021;11(1):1–15. doi:10.1038/s41598-021-01256-9
  • Victoria H, Reimar W, Ole H, et al. Diabetes in Sub Saharan Africa: epidemiology and public health implications. BMC Public Health. 2011;11:1471–2458.
  • Ling W, Huang Y, Huang Y, et al. Global trend of diabetes mortality attributed to vascular complications, 2000–2016. J Cardiovasc Diabetol. 2020;19(182):2–12.
  • Bandeira Sde M, da Fonseca LJS, Guedes Gda S, et al. Oxidative stress as an underlying contributor in the development of chronic complications in diabetes mellitus. Int J Mol Sci. 2013;14(2):3265–3284. doi:10.3390/ijms14023265
  • Papatheodorou K, Banach M, Bekiari E, et al. Complications of diabetes. J Diabetes Res. 2018;30(8):61–67.
  • Iglay K, Hannachi H, Joseph Howie P, et al. Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus. Curr Med Res Opin. 2016;32(7):1243–1252. doi:10.1185/03007995.2016.1168291
  • Skyler JS, Bakris GL, Bonifacio E, et al. Differentiation of diabetes by pathophysiology, natural history, and prognosis Diabetes. Am Diabetes Assoc Inc. 2017;66:1.
  • Orozco-Morales M, Soca-Chafre G, Barrios-Bernal P, et al. Interplay Cancer, between cellular and molecular inflammatory mediators in lung. Inflamm Mediat Journal. 2016;34(9):46–108.
  • Marchetti C, Romito A, Musella A, et al. Combined plasma fibrinogen and neutrophil lymphocyte ratio in ovarian cancer prognosis may play a role? Int J Gynecol Cancer. 2018;28(5):939–944. doi:10.1097/IGC.0000000000001233
  • Fei X, Xing M, Wo M, et al. Thyroid stimulating hormone and free triiodothyronine are valuable predictors for diabetic nephropathy in patient with type 2 diabetes. Ann Trans Med. 2018;6(15):30–35. doi:10.21037/atm.2018.07.07
  • Kraakman MJ, Lee MKS, Al-Sharea A, et al. Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes. J Clin Invest. 2017;127(6):2133–2147. doi:10.1172/JCI92450
  • Ebrahim H, Fiseha T, Ebrahim Y, et al. Comparison of hematological parameters between type 2 diabetes mellitus patients and healthy controls at Dessie comprehensive specialized hospital, Northeast Ethiopia: comparative cross-sectional study. PLoS One. 2022;17(7):e0272145. doi:10.1371/journal.pone.0272145
  • Fu W, Fu H, Ye W, et al. Peripheral blood neutrophil-to-lymphocyte ratio in inflammatory bowel disease and disease activity: a meta-analysis. Int Immunopharmacol. 2021;101(10):82–85. doi:10.1016/j.intimp.2021.108235
  • Gemenetzis G, Bagante F, Griffin J, et al. Neutrophil-to-lymphocyte ratio is a predictive marker for invasive malignancy in intraductal papillary mucinous neoplasms of the pancreas:339–345. Ann Surg. 2017;266(2):339–345. doi:10.1097/SLA.0000000000001988
  • Patel A, Ravaud A, Motzer R, et al. Neutrophil-to-lymphocyte ratio as a prognostic factor of disease-free survival in postnephrectomy high-risk locoregional renal cell carcinoma: analysis of the S-TRAC trial. Clin Cancer Res. 2020;26(18):4863–4868. doi:10.1158/1078-0432.CCR-20-0704
  • Liang T, Chen J, Xu G, et al. Platelet-to-lymphocyte ratio as an independent factor was associated with the severity of ankylosing spondylitis. Front Immunol. 2021;12:214–276. doi:10.3389/fimmu.2021.760214
  • Zeng J, Min Chen QF, Feng Q, et al. The platelet-to-lymphocyte ratio predicts diabetic retinopathy in type 2 diabetes mellitus. Diabetes, Metab Syndr Obes Targets Ther. 2022;15:3617–3626. doi:10.2147/DMSO.S378284
  • Yue S, Zhang J, Wu J, et al. Use of the monocyte-to-lymphocyte ratio to predict diabetic retinopathy. Int J Environ Res Public Heal. 2015;12(8):10009–10019. doi:10.3390/ijerph120810009
  • Kocak MZ, Aktas G, Erkus E, et al. Mean platelet volume to lymphocyte ratio as a novel marker for diabetic nephropathy. J Coll Physicians Surg Pakistan. 2018;28(11):844–847. doi:10.29271/jcpsp.2018.11.844
  • Gebreegziabher E, Astawesegn F, Anjulo A, et al. Urban health extension services utilization in bishoftu Town, Oromia Regional State, Central Ethiopia. BMC Health Serv Res. 2017;17(1):1–10. doi:10.1186/s12913-016-1943-z
  • Gedamu S, Sendo E, Daba W, Talbott EO. Congenital anomalies and associated factors among newborns in Bishoftu General Hospital, Oromia, Ethiopia: a retrospective study. J Environ Public Health. 2021;2021:1–6. doi:10.1155/2021/2426891
  • Biadgo B, Melku M, Abebe S, et al. Hematological indices and their correlation with fasting blood glucose level and anthropometric measurements in type 2 diabetes mellitus patients in Gondar, Northwest Ethiopia. J Diabetes Metab Syndr Obes Targets Ther. 2016;9:91–99. doi:10.2147/DMSO.S97563
  • VanVoorhis CW, Morgan BL. Understanding power and rules of thumb for determining sample sizes. Tutor Quant Methods Psychol. 2007;3(2):43‐50.
  • Ivanov TD. American Diabetes Association. Stand Med Care Diabetes-2017. 2017;6(1):47–63.
  • Centers for Disease Control and Prevention. Laboratory procedure manual for fasting glucose by roche cobas C311. 2017. Available from: https://wwwn.cdc.gov/nchs/data/nhanes/2015-2016/labmethods/GLU_I_MET_C311.pdf. Accessed 27 December 2023.
  • Grigg A Europe, Sysmex XN-550 complete blood count and parameters whole blood-standard operating procedure. 2019;1–25.
  • Jaman MS, Rahman MS, Swarna RR, et al. Diabetes and red blood cell parameters. Ann Clin Endocrinol Metab. 2018;2(1):1–9.
  • Alamri BN, Bahabri A, Aldereihim AA, et al. Hyperglycemia effect on red blood cells indices. Eur Rev Med Pharmacol Sci. 2019;23(5):2139–2150. doi:10.26355/eurrev_201903_17259
  • Sefil F, Ulutas KT, Dokuyucu R. Investigation of neutrophil lymphocyte ratio and blood glucose regulation in patients with type 2 diabetes mellitus. J Int Med Res. 2014;42(2):581–588. doi:10.1177/0300060513516944
  • Ulu SM, Dogan M, Ahsen A, et al. Neutrophil-to-lymphocyte ratio as a quick and reliable predictive marker to diagnose the severity of diabetic retinopathy. DIABETES Technol Ther. 2013;15(11):943–947. doi:10.1089/dia.2013.0097
  • Karabulut B, Arcagok BC. New diagnostic possibilities for early onset neonatal sepsis: red cell distribution width to platelet ratio. Fetal Pediatr Pathol. 2020;39(4):297–306. doi:10.1080/15513815.2019.1661051
  • Dutta S, Qureshi Z, Surana V, et al. Neutrophil‑lymphocyte Ratio is a Novel Reliable Predictor of Nephropathy, Retinopathy, and Coronary Artery Disease in Indians with Type‑2 Diabetes. Indian J Endocrinol Metab. 2017;21(6):865–869.
  • Wang JR, Chen KY, Chi C. Association between neutrophil‑to‑lymphocyte ratio, platelet‑to‑lymphocyte ratio, and diabetic retinopathy. Diabetol Metab Syndr. 2020;12:1–10. doi:10.1186/s13098-019-0485-z
  • Shams N, Osmani MH. Newly diagnosed anemia in admitted diabetics, frequency, etiology and associated factors. J Coll Physicians Surg Pakistan. 2015;25(4):242–246.
  • Trevest K, Treadway H, Hawkins-van DCG, Bailey AA, Abdelhafiz AH. Prevalence and determinants of anemia in older people with diabetes attending an outpatient clinic: a cross-sectional audit. Clin Diabetes. 2014;32(4):158. doi:10.2337/diaclin.32.4.158
  • Tujuba T, Ayele BH, Fage SG, et al. Anemia among adult diabetic patients attending a general hospital in Eastern Ethiopia: diabetes. Metab Syndr Obes. 2021;14:467–476. doi:10.2147/DMSO.S289298
  • Taderegew MM, Gebremariam T, Tareke AA, Woldeamanuel GG. Anemia and its associated factors among type 2 diabetes mellitus patients. J Blood Med. 2020;11:47–58. doi:10.2147/JBM.S243234
  • Hosseini MS, Rostami Z, Saadat A, et al. Anemia and microvascular complications in patients with type 2 diabetes mellitus. Nephro Urol Mon. 2014;6(4):e19976. doi:10.5812/numonthly.19976
  • Thambiah SC, Samsudin IN, George E, et al. Anaemia in type 2 diabetes mellitus (T2DM) patients in Hospital Putrajaya. Malaysian J Med Heal Sci. 2015;11(1):49–62.
  • Duman TT, Aktas G, Atak BM, et al. Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus. African Heal Sci. 2019;19(1):1602–1606. doi:10.4314/ahs.v19i1.35
  • Pujani M, Gahlawat H, Agarwal C, Chauhan V, Singh K, Lukhmana S. Can they serve as biomarkers of glycemic control or development of complications in evaluation of type 2 diabetes mellitus ? Iraqi J Hematol. 2018;7(2):72–78. doi:10.4103/ijh.ijh_8_18
  • Kadić HS. Mean platelet volume predicts the glycemic control deterioration in diabetes mellitus type 2 patients. J Med Glas. 2016;13(1):1–7.
  • Farooqui R, Afsar AI, Afroze IA. Role and significance of hematological parameters in diabetes mellitus. Ann Pathol Lab Med. 2019;6(3):159–162. doi:10.21276/apalm.2355
  • Nurlaelatiningsih SS. Correlation between neutrophil- lymphocyte ratio and cardiac autonomic neuropathy in diabetes mellitus type 2 patients. Int J Integr Heal Sci. 2017;5(1):15–20.
  • Adnyani PY, Mahartini NN, Herawati S, et al. Comparison of Neutrophil to Lymphocyte Ratio (NLR) and Lymphocyte to Monocyte Ratio (LMR) values in controlled and uncontrolled Type 2 Diabetes Mellitus (T2DM) patient. Bali Med J. 2021;10(2):2302–2914. doi:10.15562/bmj.v10i2.2501
  • Angelousi EL, Larger E. Anaemia, a common but often unrecognized risk in diabetic patients: a review. Diabetes Metab. 2015;41(1):18–27. doi:10.1016/j.diabet.2014.06.001
  • Xu T, Weng Z, Chu P, et al. The relationship between neutrophil-to-lymphocyte ratio and diabetic peripheral neuropathy in Type 2 diabetes mellitus. Medicine. 2017;96(45):1–6.
  • Sari NKP, WandeIN I, Ketut Suega IK, et al. The relationship between hepcidin and anemia in controlled and uncontrolled Type-2 Diabetes Mellitus (T2DM) patients. Indones J Biomed Sci. 2021;15(2):140–144. doi:10.15562/ijbs.v15i2.361
  • Jaaban M, Zetoune AB, Hesenow S, et al. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as novel risk markers for diabetic nephropathy in patients with type 2 diabetes. Heliyon. 2021;7(7):e07564. doi:10.1016/j.heliyon.2021.e07564
  • Huang Q, Wu WM, Kumaran EAP, et al. Monocyte–lymphocyte ratio is a valuable predictor for diabetic nephropathy in patients with type 2 diabetes. Medicine. 2020;18(1):1–7. doi:10.1186/s12916-019-1443-1
  • Moursy EY, Megallaa MH, Mouftah RF, et al. Relationship Between Neutrophil-Lymphocyte Ratio and Microvascular Complications. Am J Intern Med. 2015;3(6):250–255.
  • King DE, Mainous A, Buchanan PW, Pearson WS. C-reactive protein and glycemic control in adults with diabetes. Diabetes Care. 2013;26(5):1535–1539. doi:10.2337/diacare.26.5.1535
  • Craig KJ, Williams JD, Riley SG, Smith H, Owens WD. Anemia and diabetes in the absence of nephropathy. Diabetes Care. 2015;28(5):1118–1123. doi:10.2337/diacare.28.5.1118
  • Samuel R, Tejaswi N, Kumar PN, et al. Clinical significance of screening for anaemia in diabetic patients. Int J Pharm Sci Rev Res. 2018;48(2):20–24.
  • Lippi G, Mercadanti M, Aloe R, et al. Erythrocyte mechanical fragility is increased in patients with type 2 diabetes. Eur J Intern Med. 2012;23(2):150–153. doi:10.1016/j.ejim.2011.11.004
  • Cohen J, Vincent J, Adhikari N, Machado F, Angus CT. Sepsis: a roadmap for future research. Lancet Infect Dis. 2018;10(2):8.